$RZLT

$4.11 +$0.29 (7.59%) Close

$RZLT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$RZLT Management Team

Dr. Sunil Karnawat

Chief Commercial Officer

Age 58

Compensation -

Sex Male

Mr. Nevan Elam

Acting Chairman of the Board

Chief Executive Officer

Age 57

Compensation $2.851M USD

Sex Male

Mr. Daron Evans

Chief Financial Officer

Age 52

Compensation $1.716M USD

Sex Male

Dr. Brian Roberts

Chief Medical Officer

Age 51

Compensation $1.435M USD

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Sunil Karnawat Chief Commercial Officer	58	-	Male
Mr. Nevan Elam Acting Chairman of the Board Chief Executive Officer	57	$2.851M USD	Male
Mr. Daron Evans Chief Financial Officer	52	$1.716M USD	Male
Dr. Brian Roberts Chief Medical Officer	51	$1.435M USD	Male

Board of Directors

From the proxy statement filed Oct 21, 2026

Directors

serving now

Independent

5 of 7

stated in the proxy

Average tenure

6.3 years

from year joined

CEO also chairs the board

Yes

Nevan Charles Elam

Director	Age	On board	Independent	Committees	Other public boards	Pay
Nevan Charles Elam Board chair, CEO	59	2013 13 years	Not independent	None stated	Savara, Inc.	Paid as CEO
Erik Harris	56	2025 1 year	Independent	Compensation Committee	None stated	Not stated
Gil Labrucherie	55	2019 7 years	Independent	Audit Committee · Chair	None stated	Not stated
Nerissa Kreher	54	2021 5 years	Independent	Compensation Committee Nominating and Governance Committee · Chair	Xeris Biopharma Holdings, Inc.	Not stated
Philippe Fauchet	68	2020 6 years	Independent	Audit Committee	None stated	Not stated
Wladimir Hogenhuis	62	2021 5 years	Independent	Audit Committee Compensation Committee · Chair	None stated	Not stated
Young-Jin Kim	69	2019 7 years	Not independent	None stated	Genexine Inc.	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

3 disclosed in the proxy filed Oct 21, 2026

Handok

$5.0 million

July 2024

Purchase of 1,250,000 shares of common stock at $4.00 per share in the 2024 Private Placement

Open in proxy

Handok

Amount not stated

May 2025

Purchase of 1,230,769 shares of common stock at $3.25 per share in the 2025 Private Placement; aggregate proceeds of this and the Nerissa Kreher purchase stated as $4.0 million

Open in proxy

Nerissa Kreher

Amount not stated

May 2025

Purchase of 3,076 shares of common stock at $3.25 per share in the 2025 Private Placement

Open in proxy

Comments

Company Executives

$RZLT Management Team

Dr. Sunil Karnawat

Mr. Nevan Elam

Mr. Daron Evans

Dr. Brian Roberts

Board of Directors

Related-party transactions